Learn More
Medchemexpress LLC Dbco-peg4-va-pbd | 2241644-09-5 | >98.0% | 1430.6 | C80H87N9O16 | 10 MG

Supplier: Medchemexpress LLC HY13343310MG
DBCO-PEG4-VA-PBD is a drug-linker conjugate designed for antibody-drug conjugate (ADC) research and click chemistry applications. It combines a dibenzocyclooctyne (DBCO) group for strain-promoted alkyne-azide cycloaddition (SPAAC) with a PEG4-valine-alanine spacer and a pyrrolobenzodiazepine (PBD) cytotoxic payload. The compound is supplied for research use and is handled under low-temperature, inert storage conditions.
- Contains DBCO group for strain-promoted alkyne-azide cycloaddition (SPAAC).
- Includes PEG4-valine-alanine spacer to provide linker stability.
- Delivers a pyrrolobenzodiazepine (PBD) cytotoxic payload for ADC applications.
- Molecular weight approximately 1,430.6 Da.
- Soluble in DMSO at 120 mg/mL; ultrasonic agitation recommended.
- Store at -80°C under nitrogen to maintain stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.